ARUP's Laboratory Test Directory

LMNA-Related Disorders (LMNA) Sequencing : 2004543
[ image for: Patient History for Laminopathies]
Patient History for Laminopathies
[ image for: Additional Technical Information]
Additional Technical Information


Mnemonic: LMNA FGS

Ordering Recommendation: Diagnostic testing for LMNA-related disorders. Carrier screening for LMNA-related disorders. Predictive testing for LMNA-related disorders.
Methodology: Polymerase Chain Reaction/Sequencing
Performed: Varies
Reported: Within 21 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data: Background Information for LMNA-Related Disorders (LMNA) Sequencing:
Characteristics of Laminopathies:
Mutations in the lamin A/C (LMNA) gene cause a broad range of clinical diseases collectively termed laminopathies. Clinical findings are highly variable.
Hutchinson-Gilford progeria syndrome (HGPS): Accelerated aging, profound failure to thrive, characteristic facies, alopecia, joint degeneration, growth retardation. Average life span is 13 years.
Emery-Dreifuss muscular dystrophy, type 2 (EDMD2): Joint contractures, progressive muscle weakness and wasting, and cardiac disease with conduction defects and arrhythmias.
Limb-girdle muscular dystrophy, type1B (LGMD1B): Progressive proximal lower limb weakness and atrioventricular cardiac conduction complications.
Charcot-Marie-Tooth, type 2B1 (CMT2B1): Symmetrical distal muscle weakness and atrophy, depressed or absent tendon reflexes.
Familial partial lipodystrophy, Dunnigan type (FLPD): Post-pubescent progressive loss of subcutaneous fat from the extremities and excess fat accumulation on the face and neck.
Dilated cardiomyopathy (DCM): Progressive ventricular dilation and impaired systolic function leading to congestive heart failure.
Mandibuloacral dysplasia (MAD): Post-natal growth retardation, craniofacial and skeletal anomalies, mottled cutaneous pigmentation.
Atypical Werner syndrome (WS): Progeria-like syndrome with features of partial alopecia, premature aging, short stature, hypogonadism, osteoporosis, premature atherosclerosis, weak voice, cataracts.
Restrictive Dermopathy (RD): Skin tightness causes fetal akinesia or hypokinesia deformation sequence; disease is lethal.
Incidence:
At least 1 in 8 million for HGPS; DCM occurs in approximately 1 in 2,500 and is familial in 30-60 percent of cases of which approximately 8 percent are caused by LMNA gene mutations; unknown for other LMNA-related conditions.
Inheritance:
Laminopathies are inherited as autosomal dominant, recessive, or de novo.
Penetrance:
Complete for HGPS; variable for other LMNA-related disorders.
Cause:
Pathogenic LMNA gene mutations.
Clinical Sensitivity:
Clinical sensitivity is dependant upon the specific LMNA-related disorder.
Methodology:
Bidirectional sequencing of the LMNA coding region and intron-exon boundaries.
Analytical Sensitivity and Specificity:
99 percent.
Limitations
: Rare diagnostic errors can occur due to primer site mutations. Some regulatory region mutations, deep intronic mutations, and large deletion/duplications will not be detected.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

See Compliance Statement C: www.aruplab.com/CS
CPT Code(s): 81406
Cross References: Atypical Werner Syndrome (LMNA-Related Disorders (LMNA) Sequencing) , Dilated Cardiomyopathy (LMNA-Related Disorders (LMNA) Sequencing) , Emery-Dreifuss Muscular Dystrophy Type 2 (LMNA-Related Disorders (LMNA) Sequencing) , Familial Partial Lipodystrophy, Dunnigan Type (LMNA-Related Disorders (LMNA) Sequencing) , Hutchinson-Gilford Progeria (LMNA-Related Disorders (LMNA) Sequencing) , Laminopathies (LMNA-Related Disorders (LMNA) Sequencing) , Limb Girdle Muscular Dystrophy 1B (LMNA-Related Disorders (LMNA) Sequencing) , Mandibulo-Acral Dysplasia (LMNA-Related Disorders (LMNA) Sequencing) , Restrictive Dermopathy (LMNA-Related Disorders (LMNA) Sequencing)